These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6773073)

  • 1. TRH on rat conditioned avoidance behavior: interaction with brain catecholamines.
    Mora S; Nasello AG; Fieschi L
    Pharmacol Biochem Behav; 1980 Jul; 13(1):137-9. PubMed ID: 6773073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of LHRH on rat conditioned avoidance behavior: interaction with brain catecholamines.
    Nasello AG; Bydlowski CR; Felicio LF
    Pharmacol Biochem Behav; 1990 Dec; 37(4):639-42. PubMed ID: 1982693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desynchronized sleep deprivation: learning deficit and its reversal by increased catecholamines.
    Hartmann E; Stern WC
    Physiol Behav; 1972 Apr; 8(4):585-7. PubMed ID: 5038128
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of thyrotropin-releasing hormone on catecholamine concentration in various structures of the rat brain.
    Niimi M; Takahara J; Fujino H; Aoki Y
    Folia Psychiatr Neurol Jpn; 1983; 37(2):121-7. PubMed ID: 6423471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of acute administration of thyrotropin-releasing hormone on conditioned active avoidance learning and passive avoidance learning in rats (author's transl)].
    Hayashi T
    Nihon Naibunpi Gakkai Zasshi; 1981 May; 57(5):747-61. PubMed ID: 6793411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats.
    Thompson BL; Rosen JB
    Neuropeptides; 2000 Feb; 34(1):38-44. PubMed ID: 10688967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on the interaction of thyrotropin-releasing hormone (TRH) and MK-771 with central noradrenergic mechanisms.
    Lotti VJ; Yarbrough GG; Clineschmidt BV
    Psychopharmacology (Berl); 1980; 70(2):145-8. PubMed ID: 6776573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain catecholamines modifications. The effects on memory facilitation induced by oxotremorine in mice.
    Huygens P; Baratti CM; Gardella JL; Filinger E
    Psychopharmacology (Berl); 1980; 69(3):291-4. PubMed ID: 6774370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of thyrotropin-releasing hormone on the behaviour of rats pretreated with alpha-methyltyrosine.
    Kulig BM
    Neuropharmacology; 1975 Jul; 14(7):489-92. PubMed ID: 807866
    [No Abstract]   [Full Text] [Related]  

  • 12. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disruption of conditioned avoidance response following selective depletion of brain catechol amines.
    Hanson LC
    Psychopharmacologia; 1965 Jul; 8(2):100-10. PubMed ID: 5853733
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence of catecholaminergic involvement in the behavioral effects of luteinizing hormone releasing hormone in rats.
    Mora S; Diaz-Veliz G
    Pharmacol Biochem Behav; 1986 Mar; 24(3):433-8. PubMed ID: 3517886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP; Breese GR; Prange AJ
    Pharmacol Biochem Behav; 1975; 3(4):665-70. PubMed ID: 810812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice.
    Ushijima I; Yamada K; Furukawa T; Noda Y; Todoroki M; Inanaga K
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):257-63. PubMed ID: 6778401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of thyrotropin-releasing hormone and histidyl-proline-diketopiperazine disrupts the acquisition of a food rewarded task by a non-aversive action.
    Andrews JS; Sahgal A
    Regul Pept; 1983 Dec; 7(4):373-83. PubMed ID: 6422515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRH-induced behavioral arousal in developing rats pretreated with 6-hydroxydopa.
    Nomura Y; Oki K
    Pharmacol Biochem Behav; 1980 Jun; 12(6):925-30. PubMed ID: 6773071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.